financetom
Business
financetom
/
Business
/
Update: SSR Mining Provides 2025 Operating Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: SSR Mining Provides 2025 Operating Guidance
Mar 31, 2025 8:44 AM

11:22 AM EDT, 03/31/2025 (MT Newswires) -- (Adds comment and updates shares.)

SSR Mining ( SSRGF ) was last seen down 7.7% after the company on Monday issued its 2025 operating guidance.

The miner expects to raise 2025 gold-equivalent production to a range of 410,000 to 480,000 ounces, up from 399,267 GEOs in 2024. The target excludes any output from a potential reopening of its Copler mine in Turkiye, which was suspended in February, 2024, following a deadly collapse of the mine's heap-leach pad.

SSR said the addition of the Cripple Creek & Victor (CC&V) mine in Colorado to its portfolio drove the expected production increase. On Feb. 28, the company closed the purchase of the mine from Newmont ( NEM ) . As of Dec. 31, 2024, the mine hosted 2.4 million ounces of gold, an 85% increase.

"We entered 2025 with positive momentum," said executive chair Rod Antal. "Our Americas assets, recently bolstered by the acquisition of CC&V, are well positioned for significant production growth and strong cash flows in 2025."

Exclusive of care and maintenance costs at the Copler mine, SSR expects its 2025 consolidated all-in sustaining costs to reach US$1,890 to US$1,950 per ounce.

SSR said technical work and initial development activities have continued at the Hod Maden project in Turkey, planning to spend US$60 million to US$100 million in project development capital for 2025.

"We see attractive and low capital intensity opportunities to potentially extend the mine lives at each of these assets going forward and will continue to progress technical work through the year," Antal said.

National Bank Financial maintained its sector-perform rating and $18.00 price target following the guidance.

According to National Bank, SSR's production guidance was in line with forecasts and shows modest growth year over year while costs and capex were above the bank's estimate, though still show sizable

SSR shares were last seen down $1.20 to $14.38 on the Toronto Stock Exchange.

Price: 14.40, Change: -1.18, Percent Change: -7.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sector Update: Consumer
Sector Update: Consumer
Aug 8, 2025
03:22 PM EDT, 08/08/2025 (MT Newswires) -- Consumer stocks advanced late Friday afternoon with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 0.2%. In corporate news, Sweetgreen ( SG ) shares tumbled 26%, a day after the company posted a wider-than-expected loss and revenue miss in Q2 and...
Trump fires IRS commissioner, Bessent named acting head
Trump fires IRS commissioner, Bessent named acting head
Aug 8, 2025
(Reuters) -U.S. President Donald Trump is removing Billy Long as the commissioner of the Internal Revenue Service and Treasury Secretary Scott Bessent will temporarily serve as acting commissioner, a White House official and a source familiar with the matter said on Friday. The New York Times, which first reported the news, said Long, a former congressman from Missouri, was expected...
Gilead Sciences' HIV Drug Yeztugo Unlikely to Deliver Significant Contributions Until 2028, Oppenheimer Says
Gilead Sciences' HIV Drug Yeztugo Unlikely to Deliver Significant Contributions Until 2028, Oppenheimer Says
Aug 8, 2025
03:22 PM EDT, 08/08/2025 (MT Newswires) -- Gilead Sciences' ( GILD ) recently launched HIV prevention drug Yeztugo is unlikely to generate any significant financial impact until 2028, Oppenheimer said in a note emailed Friday. The brokerage said it sees revenue growth for the biopharmaceutical company of 5% to 6% by 2028, primarily driven by antibody-drug conjugate Trodelvy's 1L expansion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved